ES2011242B3 - Fenilacetaldehidos con sustituyentes basicos. obtencion y medicamentos que los contienen. - Google Patents

Fenilacetaldehidos con sustituyentes basicos. obtencion y medicamentos que los contienen.

Info

Publication number
ES2011242B3
ES2011242B3 ES86116409T ES86116409T ES2011242B3 ES 2011242 B3 ES2011242 B3 ES 2011242B3 ES 86116409 T ES86116409 T ES 86116409T ES 86116409 T ES86116409 T ES 86116409T ES 2011242 B3 ES2011242 B3 ES 2011242B3
Authority
ES
Spain
Prior art keywords
basic
phenylacetaldehyde
substitutes
medicines
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES86116409T
Other languages
English (en)
Inventor
Werner Seitz
Verena Baldinger
Josef Gries
Dieter Lenke
Manfred Raschack
Klaus Ruebsamen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Application granted granted Critical
Publication of ES2011242B3 publication Critical patent/ES2011242B3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
ES86116409T 1985-12-05 1986-11-26 Fenilacetaldehidos con sustituyentes basicos. obtencion y medicamentos que los contienen. Expired - Lifetime ES2011242B3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853542994 DE3542994A1 (de) 1985-12-05 1985-12-05 Basisch substituierte phenylacetaldehyde, ihre herstellung und diese enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
ES2011242B3 true ES2011242B3 (es) 1990-01-01

Family

ID=6287695

Family Applications (1)

Application Number Title Priority Date Filing Date
ES86116409T Expired - Lifetime ES2011242B3 (es) 1985-12-05 1986-11-26 Fenilacetaldehidos con sustituyentes basicos. obtencion y medicamentos que los contienen.

Country Status (9)

Country Link
US (1) US4723039A (es)
EP (1) EP0225543B1 (es)
JP (1) JPS62132844A (es)
AT (1) ATE46687T1 (es)
AU (1) AU587661B2 (es)
CA (1) CA1268471A (es)
DE (2) DE3542994A1 (es)
ES (1) ES2011242B3 (es)
ZA (1) ZA869156B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3603032A1 (de) * 1986-01-31 1987-08-06 Basf Ag Basisch substituierte phenylacetonitrile, ihre herstellung und diese enthaltende arzneimittel
IT1205124B (it) * 1987-06-05 1989-03-15 Simens Soteta Italiana Medicin Composto attivo nella terapia carciovascolare
US5171753A (en) * 1991-05-15 1992-12-15 A. H. Robins Company, Incorporated Derivatives of 2-amino-1-phenylethanol having antiulcer activity
US9504747B2 (en) 2013-03-08 2016-11-29 Novartis Ag Lipids and lipid compositions for the delivery of active agents
AU2014224205C1 (en) * 2013-03-08 2019-04-04 Novartis Ag Lipids and lipid compositions for the delivery of active agents
ES2949172T3 (es) 2014-07-16 2023-09-26 Novartis Ag Método de encapsulamiento de un ácido nucleico en un hospedante de nanopartículas lipídicas

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2628255A (en) * 1951-01-02 1953-02-10 Dow Chemical Co Production of arylacetaldehydes
DE924862C (de) * 1952-05-06 1955-03-10 Sterling Drug Inc Verfahren zur Herstellung von 1-2, 2-Diphenyl-4-dimethylamino-1-pentanal
GB747866A (en) * 1952-05-06 1956-04-18 Sterling Drug Inc Improvements in or relating to an amino-substituted-pentanal and the preparation thereof
DE1154810B (de) * 1961-04-01 1963-09-26 Knoll Ag Verfahren zur Herstellung basisch substituierter Phenylacetonitrile
CH407216A (de) * 1962-09-20 1966-02-15 Roger Prof Dessoulavy Elektronische Unterbrecherschaltung
FR1469468A (fr) * 1964-06-05 1967-02-17 Thomae Gmbh Dr K Procédé pour fabriquer des nouveaux pseudoindoles basiquement substitués
US3927110A (en) * 1974-01-18 1975-12-16 Cosden Oil & Chem Co Thermolysis of styrene oxide
DE3144150A1 (de) * 1981-04-10 1982-12-09 Basf Ag, 6700 Ludwigshafen (omega)-cyan-1,(omega)-diphenyl-azaalkan-derivate, ihre herstellung und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
AU6610086A (en) 1987-06-11
EP0225543A1 (de) 1987-06-16
EP0225543B1 (de) 1989-09-27
DE3665861D1 (en) 1989-11-02
ATE46687T1 (de) 1989-10-15
DE3542994A1 (de) 1987-06-11
ZA869156B (en) 1988-08-31
US4723039A (en) 1988-02-02
JPS62132844A (ja) 1987-06-16
AU587661B2 (en) 1989-08-24
CA1268471A (en) 1990-05-01

Similar Documents

Publication Publication Date Title
DK173883D0 (da) Substituerede 8-phenylxanthiner
MX9203363A (es) Nuevos derivados de acido 3-aminopropansulfonico y composiciones farmaceuticas que los contienen.
MX9203380A (es) Derivados de carbazolil-(4)-oxi-propanolamina y composiciones farmaceuticas que los contienen.
AR229106A1 (es) Procedimiento para preparar derivados cis-o trans-isomericos de 4-fenil-1,2,3,4-tetrahidro-1-naftalenamina
ES520985A0 (es) Procedimiento para la preparacion de nuevos 6,11-dihidrodibenzo (b,e)-tiepin-11-n-alcohilnorescopin-eteres cuaternarios.
ES525653A0 (es) Procedimiento para preparar nuevos diazabiciclo-(3.3.1)-nonanos
FI844289L (fi) Nya polypeptider med -amylashaemmande verkan, foerfarande foer deras framstaellning, deras anvaendning och farmaceutiska preparat.
IL64292A0 (en) D-homosteroids,their manufacture and pharmaceutical compositions containing them
IL78666A0 (en) Pyridine derivatives,their preparation and pharmaceutical compositions containing them
MX156069A (es) Proceso mejorado para la preparacion de poliesteres de peso molecular elevado
ES2011242B3 (es) Fenilacetaldehidos con sustituyentes basicos. obtencion y medicamentos que los contienen.
IT8048909A0 (it) Procedimento per la preparazione di solfenammidi
ES2145234T3 (es) Derivados de la diosmetina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
MX9203642A (es) Compuestos substituidos del acido 1,3,4,9-tetrahidropirano (3,4-b)-indol-1-acetico y composiciones farmaceuticas que los contienen.
BR8700990A (pt) Processo para preparar uma composicao de organopolisiloxano
ES493375A0 (es) Procedimiento para la preparacion de mezclas de aclaradores opticos
AU6814387A (en) Phenylacetonitriles which are substituted by basic groups, their preparation and drugs containing these substances
AR222507A1 (es) Nuevas n-fenilureas,procedimientos y nuevas materias primas para obtenerlas y composiciones herbicidas que las contienen
DK328088A (da) Farmaceutisk komposition til behandling af tumorer
DK313587D0 (da) Tetrahydrobenzothiazolforbindelser, deres fremstilling og anvendelse
ES488301A0 (es) Procedimiento para la obtencion de dehidropeptidos
MX9203021A (es) Derivados de carbostirilo y composicion farmaceutica que los contiene.
IT1132528B (it) Procedimento per la preparazione di derivati del 15-idrossiimmino-e-omoeburano
FI793035A7 (fi) Uudet 2-substituoidut-3-heterosyklyyli- indolit, niiden valmistaminen ja niitä sisältävät farmaseuttiset seoksseokset.
BR8700982A (pt) Processo para curar uma composicao de organossiloxano